PDL BioPharma Inc (NASDAQ:PDLI)

7.09
BATS BZX Real-Time Price
As of 1:14pm ET
 +0.05 / +0.71%
Today’s Change
6.52
Today|||52-Week Range
10.26
-8.11%
Year-to-Date

Today’s Trading

Previous close7.04
Today’s open7.04
Day’s range6.94 - 7.11
Volume1,660,297
Average volume (3 months)3,611,377
Market cap$1.1B
Dividend yield8.46%
Data as of 1:02pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+18.28%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.8
Price/Sales2.10
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-1.42-4.92%
CLLSCellectis SA-1.23-3.56%
ACHNAchillion Pharmaceut...-0.19-1.93%
EBSEmergent BioSolution...+0.20+0.70%
Data as of 1:16pm ET, 04/01/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account